100 likes | 187 Views
Issues Related to Vaccines and HIV Testing. Annual Family Conference ACES October 11, 2007 Charles H. Woernle, MD, MPH Alabama Department of Public Health. Topics. Issues related to vaccines Human papillomavirus vaccine Influenza vaccine
E N D
Issues Related to Vaccines and HIV Testing Annual Family Conference ACES October 11, 2007 Charles H. Woernle, MD, MPH Alabama Department of Public Health
Topics • Issues related to vaccines • Human papillomavirus vaccine • Influenza vaccine • Expanded testing for human immunodeficiency virus (HIV)
Immunization Issues • Vaccines—most effective measure to prevent disease • Four related issues: • Acceptance • Access • Cost • Mandates
Human Papillomavirus Vaccine • Prevents infection from 4 types of HPV • Two types cause 90% of genital warts • Two types cause 70% of cervical cancers • Vaccine recommended for females 9-26 years of age
Issues related to HPV Vaccine • Cost • ~$300 vaccine cost for the 3-dose series • Policy • Societal acceptance—vaccine must be given before onset of sexual activity • Question of mandated vaccination
Objective 4.12 • Increase to 90 percent or more influenza immunization coverage among adults aged 65 years or older • AL baseline (1997) = 62% • US baseline (1995) = 58% • AL 2006 = 62% • US 2006 = 69%
Expanded HIV Testing • ~25% of HIV-infected persons do not know they are infected; delay results in • Illness • Spread of infection • September 2006 CDC guidelines • Offer HIV testing routinely in clinic settings • “Opt out” instead of “opt in”
ADPH Actions • Modifying informed consent to include reference to HIV as a routine test • Modifying HIV laboratory requisition slip • Suitable for use in both clinic settings and HIV counseling and testing sites • Dual approach • Individualized consent and pre-test counseling in non-clinical settings • Routine testing in clinical settings
Post-test Counseling • Tested individuals should be informed of their results • Persons with positive results need to be referred for services